Anti-viral effect of usenamine a using SARS-CoV-2 pseudo-typed viruses

被引：1
|
作者：
Li, Zijun [1 ,2 ]
Lee, Joo-Eun [2 ]
Cho, Namki [2 ]
Yoo, Hee Min [1 ,3 ]
机构：
[1] Korea Res Inst Stand & Sci KRISS, Biometrol Grp, Daejeon 34113, South Korea
[2] Chonnam Natl Univ, Res Inst Pharmaceut Sci, Coll Pharm, Gwangju 61186, South Korea
[3] Univ Sci & Technol UST, Dept Precis Measurement, Daejeon 34113, South Korea
来源：
HELIYON | 2023年 / 9卷 / 11期
基金：
新加坡国家研究基金会;
关键词：
Natural products; SARS-CoV-2; Pseudotyped viruses; Antiviral activity; Reactive oxygen species; USNIC ACID; HOSPITALIZED-PATIENTS; USNEA-BARBATA; IN-VITRO; TOCILIZUMAB; ANTIFUNGAL; EXTRACTS;
D O I：
10.1016/j.heliyon.2023.e21742
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
The escalating pandemic brought about by the novel SARS-CoV-2 virus is threatening global health, and thus, it is necessary to develop effective antiviral drugs. Usenamine A is a dibenzofuran derivative separated from lichen Usnea diffracta showing broad-spectrum activity against different viruses. We evaluate that usenamine A has antiviral effects against novel SARS-CoV-2 Delta variant pseudotyped viruses (PVs) in A549 cells. In addition, usenamine A significantly suppresses SARS-CoV-2 PV-induced mitochondrial depolarization, elevated reactive oxygen species (ROS) levels, apoptosis, and inflammation. Usenamine A also causes the SARS-CoV-2 spike protein to become less stable. Thus, usenamine A shows potential as an antiviral drug that can provide protection against COVID-19.
引用
收藏
页数：14
相关论文
共 50 条
  • [41] Highly Specific Sigma Receptor Ligands Exhibit Anti-Viral Properties in SARS-CoV-2 Infected Cells
    Ostrov, David A.
    Bluhm, Andrew P.
    Li, Danmeng
    Khan, Juveriya Qamar
    Rohamare, Megha
    Rajamanickam, Karthic
    Bhanumathy, Kalpana K.
    Lew, Jocelyne
    Falzarano, Darryl
    Vizeacoumar, Franco J.
    Wilson, Joyce A.
    Mottinelli, Marco
    Kanumuri, Siva Rama Raju
    Sharma, Abhisheak
    McCurdy, Christopher R.
    Norris, Michael H.
    PATHOGENS, 2021, 10 (11):
  • [42] A Neutralization Assay Based on Pseudo-Typed Lentivirus with SARS CoV-2 Spike Protein in ACE2-Expressing CRFK Cells
    Pisil, Yalcin
    Shida, Hisatoshi
    Miura, Tomoyuki
    PATHOGENS, 2021, 10 (02): : 1 - 13
  • [43] VIRUSES Neutralizing SARS-CoV-2
    Poeschla, Eric
    ELIFE, 2020, 9 : 1 - 4
  • [44] SARS-CoV-2 papain-like protease inhibits ISGylation of the viral nucleocapsid protein to evade host anti-viral immunity
    Rhamadianti, Aulia Fitri
    Abe, Takayuki
    Tanaka, Tomohisa
    Ono, Chikako
    Katayama, Hisashi
    Makino, Yoshiteru
    Deng, Lin
    Matsui, Chieko
    Moriishi, Kohji
    Shima, Fumi
    Matsuura, Yoshiharu
    Shoji, Ikuo
    JOURNAL OF VIROLOGY, 2024, 98 (09)
  • [45] Iodide supplementation of the anti-viral duox-lactoperoxidase activity may prevent some SARS-CoV-2 infections
    Smith, Michael L.
    Sharma, Sujata
    Singh, Tej P.
    EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2022, 76 (04) : 629 - 630
  • [46] Iodide supplementation of the anti-viral duox-lactoperoxidase activity may prevent some SARS-CoV-2 infections
    Michael L. Smith
    Sujata Sharma
    Tej P. Singh
    European Journal of Clinical Nutrition, 2022, 76 : 629 - 630
  • [47] Evaluation of acridinedione analogs as potential SARS-CoV-2 main protease inhibitors and their comparison with repurposed anti-viral drugs
    Bhardwaj, Vijay Kumar
    Singh, Rahul
    Das, Pralay
    Purohit, Rituraj
    COMPUTERS IN BIOLOGY AND MEDICINE, 2021, 128
  • [48] Inhibition of SARS-CoV-2 3CL protease by the anti-viral chimeric protein RetroMAD1
    Chan, Lee-Chin
    Yassim, Aini Syahida Mat
    Fuaad, Abdullah Al Hadi Ahmad
    Leow, Thean Chor
    Sabri, Suriana
    Yahaya, Radin Shafierul Radin
    Abu Bakar, Awang Muhammad Sagaf
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [49] sMAdCAM: IL-6 Ratio Influences Disease Progression and Anti-Viral Responses in SARS-CoV-2 Infection
    Jagtap, Dhanashree
    Bhor, Vikrant M.
    Bhowmick, Shilpa
    Kasarpalkar, Nandini
    Sagvekar, Pooja
    Kulkarni, Bhalchandra
    Pathak, Manish
    Chatterjee, Nirjhar
    Dolas, Pranam
    Palav, Harsha
    Kaginkar, Snehal
    Bhagat, Sharad
    Munshi, Itti
    Parikh, Swapneil
    Agrawal, Sachee
    Pawar, Chandrakant
    Kaneria, Mala
    Mahale, Smita D.
    Shastri, Jayanthi
    Patel, Vainav
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [50] Inhibition of SARS-CoV-2 3CL protease by the anti-viral chimeric protein RetroMAD1
    Lee-Chin Chan
    Aini Syahida Mat Yassim
    Abdullah Al Hadi Ahmad Fuaad
    Thean Chor Leow
    Suriana Sabri
    Radin Shafierul Radin Yahaya
    Awang Muhammad Sagaf Abu Bakar
    Scientific Reports, 13
12345